Apixaban: a review in venous thromboembolism

SL Greig, KP Garnock-Jones - Drugs, 2016 - Springer
Apixaban (Eliquis®) is an oral, direct factor Xa inhibitor that is available for use in the
treatment and secondary prevention of venous thromboembolism (VTE). Like other direct …
被引用次数：20 相关文章

Apixaban: A Review in Venous Thromboembolism

SL Greig, KP Garnock-Jones - Drugs, 2016 - pubmed.ncbi.nlm.nih.gov
Apixaban (Eliquis®) is an oral, direct factor Xa inhibitor that is available for use in the
treatment and secondary prevention of venous thromboembolism (VTE). Like other direct …

Apixaban: A Review in Venous Thromboembolism

SL Greig, KP Garnock-Jones - Drugs, 2016 - infona.pl
Apixaban (Eliquis®) is an oral, direct factor Xa inhibitor that is available for use in the
treatment and secondary prevention of venous thromboembolism (VTE). Like other direct …

Apixaban: A Review in Venous Thromboembolism

SL Greig, KP Garnock-Jones - Drugs, 2016 - search.proquest.com
Apixaban (Eliquis®) is an oral, direct factor Xa inhibitor that is available for use in the
treatment and secondary prevention of venous thromboembolism (VTE). Like other direct …

Apixaban: A Review in Venous Thromboembolism.

SL Greig, KP Garnock-Jones - Drugs, 2016 - europepmc.org
Apixaban (Eliquis®) is an oral, direct factor Xa inhibitor that is available for use in the
treatment and secondary prevention of venous thromboembolism (VTE). Like other direct …

Apixaban: A Review in Venous Thromboembolism.

S Greig, K Garnock-Jones - Drugs, 2016 - search.ebscohost.com
Apixaban (Eliquis) is an oral, direct factor Xa inhibitor that is available for use in the
treatment and secondary prevention of venous thromboembolism (VTE). Like other direct …

[引用][C] Apixaban: A Review in Venous Thromboembolism

SL Greig, KP Garnock-Jones - Drugs, 2016 - Adis International